Skip to main content
Shenzhen Bioeasy Biotechnology Co., Ltd. logo

Shenzhen Bioeasy Biotechnology Co., Ltd. — Investor Relations & Filings

Ticker · 300942 ISIN · CNE100004C78 Shenzhen Stock Exchange Manufacturing
Filings indexed 910 across all filing types
Latest filing 2026-02-02 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 300942

About Shenzhen Bioeasy Biotechnology Co., Ltd.

https://www.bioeasy.com

Shenzhen Bioeasy Biotechnology Co., Ltd. specializes in the development, production, and marketing of rapid testing solutions for food safety, clinical diagnosis, and animal health. The company provides a comprehensive portfolio of diagnostic products, including rapid test strips, enzyme-linked immunosorbent assay (ELISA) kits, and automated detection instruments. Its core focus areas include the detection of antibiotic residues, mycotoxins, pesticides, and foodborne pathogens in dairy, meat, seafood, and grain products. In the clinical sector, Bioeasy offers point-of-care testing (POCT) solutions for infectious diseases and chronic conditions. The company emphasizes research and development to deliver high-sensitivity, user-friendly diagnostic tools that meet international quality standards. Its products are utilized by food producers, regulatory agencies, and healthcare providers to ensure safety and quality control across the global supply chain.

Recent filings

Filing Released Lang Actions
关于控股股东及其一致行动人减持计划期限届满暨减持结果的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the expiration of a share reduction plan by the controlling shareholder and related parties, detailing the number of shares reduced, the methods used, and the impact on shareholding percentages. It includes specific data on shareholding changes and compliance with relevant securities laws and regulations. There is no financial performance data, earnings information, or management discussion. The document is a formal disclosure of shareholding changes by major shareholders, which fits the definition of a Major Shareholding Notification (MRQ). The document length is under 5,000 characters and is a direct announcement, not a report or certification. Therefore, the appropriate classification is MRQ with high confidence.
2026-02-02 Chinese
关于实际控制人部分股份解除质押及再质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from Shenzhen Yirui Biotechnology Co., Ltd. regarding the partial release and re-pledge of shares by the actual controller, Mr. Zhu Hai. It details the number of shares involved, pledge dates, pledgees, and confirms no major asset restructuring or performance compensation obligations are involved. The document is a formal disclosure about changes in share pledges by a controlling shareholder, which relates to capital structure and financing activities. It is not a financial report, earnings release, or management discussion, nor is it a voting result or board change announcement. The content fits the category of Capital/Financing Update (CAP) as it concerns share pledge and release activities affecting the company's capital structure.
2026-02-02 Chinese
关于控股股东部分股份解除质押的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding the partial release of pledged shares by the controlling shareholder of the company. It includes details about the number of shares released from pledge, the proportion of shares pledged before and after the release, and assurances about the risk status of the pledged shares. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory announcement about share pledge status, which fits best under the category of Regulatory Filings (RNS) as it does not fit into more specific categories like Share Issue/Capital Change or Director's Dealing. The document length is short and it is an announcement rather than a report or detailed filing.
2026-01-13 Chinese
关于控股股东及其一致行动人权益变动触及1%整数倍的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a detailed announcement about changes in shareholding by the controlling shareholder and its concerted parties, specifically about the reduction in shares held and the crossing of a 1% threshold in shareholding. It includes precise share counts before and after the change, the method of share reduction (centralized bidding and block trades), and compliance with relevant securities laws and regulations. The document does not contain financial statements, earnings data, or management discussion of financial results. It is not an annual or interim report, nor an earnings release or audit report. It is a notification of a major shareholding change, as it reports the crossing of a 1% shareholding threshold by significant shareholders. Therefore, the appropriate classification is Major Shareholding Notification (MRQ). The document length and content support this classification with high confidence.
2026-01-06 Chinese
关于2025年第四季度可转债转股情况的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the convertible bond (可转债) conversion situation for the fourth quarter of 2025 by Shenzhen Yirui Biotechnology Co., Ltd. It details the bond issuance, listing, conversion price adjustments, and the changes in share capital due to bond conversions. The document includes specific bond codes, conversion periods, and shareholding changes but does not contain comprehensive financial statements or detailed financial performance data. It is a regulatory announcement about bond conversion and share capital changes rather than a full financial report or earnings release. Given the nature of the content and the regulatory context, this fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as convertible bond conversions.
2026-01-05 Chinese
关于控股股东及其一致行动人权益变动触及1%整数倍的提示性公告
Major Shareholding Notification Classification · 100% confidence The document is a detailed announcement about changes in shareholding by the controlling shareholder and its concerted parties, including specific share quantities, percentages, and compliance with relevant securities laws. It reports on the reduction of shares held by major shareholders and the impact on total shareholding percentages. The document includes legal compliance statements and references to prior disclosures. There is no indication of financial statements, audit information, earnings data, or management discussion. The content fits the definition of a Major Shareholding Notification, which involves notifying changes in significant share ownership levels crossing thresholds such as 1%. The document length and detail confirm it is the notification itself, not a brief announcement or a report publication notice.
2025-12-04 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.